AKT1 and hepatocellular carcinoma: Wang et al. (37) found that reducing H3K18 lactylation at the IRS1 promoter decreases IRS1 expression, weakens the activities of PI3 K/AKT/mTOR and MAPK/ERK pathways, and suppresses the growth and metastasis of hepatocellular carcinoma cells.